What is the first‑line oral antibiotic and dosing for an otherwise healthy outpatient child under 5 years old with uncomplicated community‑acquired pneumonia?

First-Line Oral Antibiotic for Outpatient Pediatric Pneumonia <5 Years Old

For otherwise healthy outpatient children under 5 years old with uncomplicated community-acquired pneumonia, prescribe oral amoxicillin at 90 mg/kg/day divided into 2 doses (twice daily dosing). 1

Dosing Specifics

• Dose: 90 mg/kg/day
• Frequency: Divided into 2 doses (every 12 hours)
• Duration: 5 days is appropriate for uncomplicated cases 2
• Maximum daily dose: Not to exceed 4 grams/day

This high-dose amoxicillin regimen specifically targets Streptococcus pneumoniae, which remains the most important bacterial pathogen in this age group, even in the era of pneumococcal conjugate vaccines 1.

Alternative Options

If the child has a penicillin allergy:

• Non-severe allergy: Consider oral cephalosporins (cefpodoxime, cefprozil, or cefuroxime) under medical supervision 1
• Type 1 hypersensitivity: Use a macrolide (azithromycin 10 mg/kg on day 1, then 5 mg/kg/day on days 2-5) 1

If amoxicillin is unavailable or not tolerated:

• Amoxicillin-clavulanate (amoxicillin component at 90 mg/kg/day in 2 doses) 1

Clinical Reasoning

The IDSA/PIDS guidelines 1 distinguish treatment by age because:

• Children <5 years: Presumed bacterial pneumonia is primarily pneumococcal, making amoxicillin the optimal choice
• Children ≥5 years: Atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae) become more common, warranting consideration of macrolides

For the under-5 age group specifically, the twice-daily high-dose amoxicillin regimen provides:

• Excellent coverage against penicillin-susceptible and intermediate-resistant S. pneumoniae
• Good coverage against Haemophilus influenzae (though less common post-Hib vaccination)
• Superior pharmacokinetics with twice-daily dosing improving adherence

Duration of Therapy

Recent evidence supports shorter courses (3-5 days) rather than traditional 7-10 day regimens:

• The CAP-IT trial 2 demonstrated non-inferiority of 3-day versus 7-day amoxicillin courses for uncomplicated pneumonia
• However, cough resolution was slightly faster with 7 days (10 vs 12 days)
• Practical recommendation: 5 days represents a reasonable middle ground for most uncomplicated cases

Important caveat: In areas of high HIV prevalence, longer courses (7 days) should be considered, as shortened regimens have not been adequately studied in immunocompromised children 3.

When to Reassess

Treatment failure is defined as:

• Development of lower chest-wall indrawing, central cyanosis, or stridor at any time
• Persistently elevated respiratory rate at 48-72 hours 3

If no improvement occurs within 48-72 hours, further investigation is warranted, and antibiotic therapy should be reviewed 1. Consider:

• Resistant organisms
• Atypical pathogens (add macrolide)
• Complications (parapneumonic effusion)
• Non-bacterial etiology

Common Pitfalls to Avoid

1. Underdosing: The 90 mg/kg/day dose is critical—standard 40-50 mg/kg/day dosing is inadequate for pneumococcal pneumonia in the current resistance era
2. Unnecessary broad-spectrum antibiotics: Avoid starting with amoxicillin-clavulanate or cephalosporins unless specific indications exist
3. Overuse of macrolides: In children <5 years, macrolides should be reserved for true penicillin allergy or suspected atypical pathogens, not used as first-line
4. Excessive duration: Avoid reflexive 10-day courses when 5 days is sufficient for uncomplicated cases